Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Does a time delay between prostate cancer diagnosis and start of radiation treatment matter?

06.10.2004


Fox Chase Cancer Center researchers examine wait times and outcomes



Men who wait as long as three months after their prostate cancer diagnosis to receive radiation treatment do not fare worse than those who have treatment sooner. That is the result of a new study by researchers at Fox Chase Cancer Center presented today at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Atlanta, Ga.

"The time between initial diagnosis and external-beam radiation therapy can be delayed for various reasons," explained the study’s lead author, Stephen F. Andrews, D.O., chief resident in the Fox Chase radiation oncology department. Some of the reasons for delay, Andrews said, include the belief by many physicians that all prostate cancer is slow-growing, consideration of multiple treatment options and opinions, more labor-intensive treatment planning and long wait times from the start of planning to the start of treatment. Often if a delay is expected hormone therapy is prescribed.


"The time delay is a real concern for the patient, and physicians have limited data to guide them regarding the urgency of treatment. "The purpose of this study was to evaluate the effect of treatment delay on the outcome of these men who choose external-beam radiation," Andrews said.

The study looked at data for 1,498 patients treated with external-beam radiation between 1981 and 2001. The median follow-up was 57 months, with a minimum of two years. Time to treatment was defined by the interval between the first positive biopsy and the initiation of radiation therapy. Patients were categorized into four groups in relation to time to treatment: less than three months (n=589), three to six months (n=629), six to nine months (n=94) and more than nine months (n=67). A second analysis was performed which evaluated outcomes at the median time to treatment of 3.2 months.

"Our findings show that a delay, within the limits of this study, from the time of diagnosis to the start of treatment with external-beam radiation does not alter ultimate clinical outcome," Andrews stated. "Another important finding here is that the use of hormone therapy during the treatment delay does not affect outcome and should be avoided in men with favorable risk factors.

"Obviously, definitive treatment for prostate cancer should begin as soon as possible after diagnosis. However, patients and physicians can use this information to alleviate concerns over delaying treatment in order to make a well informed treatment decisions," Andrews concluded.

Colleen Kirsch | EurekAlert!
Further information:
http://www.fccc.edu

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

The interactome of infected neural cells reveals new therapeutic targets for Zika

23.01.2017 | Life Sciences

Melting solid below the freezing point

23.01.2017 | Materials Sciences

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

VideoLinks
B2B-VideoLinks
More VideoLinks >>>